600165 Ningxia Zhongke Biotechnology
- 1.82
- +0.09+5.20%
Ningxia Zhongke Biotechnology News
Express News | *ST Ningke: There are major uncertainties in the company's pre-restructuring and restructuring procedures
Express News | *ST Ningke: The company and its subsidiaries have not received court documents to accept pre-restructuring and restructuring
The ST sector fluctuated and rebounded, and more than 30 ST stocks, including ST Jiawo, *ST Ningke, ST Xuefa, *ST Meixun, *ST Boxin, and ST Sansheng, rose or stopped.
The ST sector fluctuated and rebounded, and more than 30 ST stocks, including ST Jiawo, *ST Ningke, ST Xuefa, *ST Meixun, *ST Boxin, and ST Sansheng, rose or stopped.
*ST Ningke (600165.SH): There is significant uncertainty about the restructuring, and there is a risk of bankruptcy due to failure of the restructuring
*ST Ningke (600165.SH) issued an announcement. The company's stock fell to a halt on May 10, 2024, at 2...
*ST Ningke (600165.SH) was sued by the Huinong District Branch of the Bank of China due to a loan contract dispute involving 187 million yuan
*ST Ningke (600165.SH) issued an announcement. Due to a financial loan contract dispute, the Huinong District Branch of the Bank of China filed a “Civil Complaint” with the Shizuishan Intermediate People's Court as a plaintiff to file lawsuits against the defendants Shanghai Zhongneng Enterprise Development (Group) Co., Ltd. (Shanghai Zhongneng), Yu Jianming, the company, Zhongke New Materials, and Huahui Environmental Protection. The amount involved was RMB 187 million.
Debt risk intensified*ST Ningke (600165.SH) subsidiary Zhongke New Materials was required to repay a total of 195 million yuan in loan principal and interest in advance
*ST Ningke (600165.SH) issued an announcement. The company and its holding subsidiary Ningxia Zhongke Biotechnology New Materials Co., Ltd...
Express News | *ST Ningke: No documents have been received from the court to accept the pre-restructuring and restructuring. There is significant uncertainty about whether the company can enter the pre-restructuring and restructuring process. The company's shares have b
*ST Ningke (600165.SH) intends to apply to the court for reorganization and pre-restructuring
*ST Ningke (600165.SH) issued an announcement. There is uncertainty about whether the company can completely resume work and resume production, and maintain...
With A 57% Price Drop For Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165) You'll Still Get What You Pay For
Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165) shares have had a horrible month, losing 57% after a relatively good period beforehand. For any long-term shareholders, the last month ends a ye
Express News | *ST Ningke: The subsidiary Zhongke New Materials is currently discontinued
Express News | *ST Ningke will perform the market on the ground in the afternoon
ST Ningke (600165.SH) announced first-quarter results with a net loss of 51.4546 million yuan
ST Ningke (600165.SH) released its report for the first quarter of 2024, with revenue of 53.8967 million...
Express News | ST Ningke: Trading of the company's shares will be suspended for one day from the opening of the market on April 29, 2024
Express News | ST Ningke performed the market on the ground in the afternoon, with a turnover of nearly 200 million yuan.
ST Ningke opened the recession board in the afternoon.
ST Ningke opened the recession board in the afternoon.
ST Ningke (600165.SH), which fell to a halt for 14 consecutive years, and its subsidiary Zhongke New Materials were applied for pre-restructuring by creditors
ST Ningke (600165.SH) issued an announcement. On April 22, 2024, the company and its subsidiary Ningxia Zhongke...
Express News | ST Ningke: Elects Hu Chunhai as Chairman
Express News | ST Ningke: The subsidiary Zhongke New Materials is not expected to resume normal production within 1 month
Express News | ST Ningke: The company found no media reports or market rumors requiring clarification or response
Express News | Ningke Biotech “wears a hat” on the next trading day
Analysis
Price Target
No Data
